» Articles » PMID: 32282513

Optic Nerve Regeneration: How Will We Get There?

Overview
Specialties Neurology
Ophthalmology
Date 2020 Apr 14
PMID 32282513
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Restoration of vision in patients blinded by advanced optic neuropathies requires technologies that can either 1) salvage damaged and prevent further degeneration of retinal ganglion cells (RGCs), or 2) replace lost RGCs.

Evidence Acquisition: Review of scientific literature.

Results: In this article, we discuss the different barriers to cell-replacement based strategies for optic nerve regeneration and provide an update regarding what progress that has been made to overcome them. We also provide an update on current stem cell-based therapies for optic nerve regeneration.

Conclusions: As neuro-regenerative and cell-transplantation based strategies for optic nerve regeneration continue to be refined, researchers and clinicians will need to work together to determine who will be a good candidate for such therapies.

Citing Articles

Electric field stimulation directs target-specific axon regeneration and partial restoration of vision after optic nerve crush injury.

Kim T, Iseri E, Peng M, Medvidovic S, Silliman T, Pahlavan P PLoS One. 2025; 20(1):e0315562.

PMID: 39787061 PMC: 11717274. DOI: 10.1371/journal.pone.0315562.


Whole-eye transplantation: Current challenges and future perspectives.

Scarabosio A, Surico P, Tereshenko V, Singh R, Salati C, Spadea L World J Transplant. 2024; 14(2):95009.

PMID: 38947970 PMC: 11212585. DOI: 10.5500/wjt.v14.i2.95009.


Neuroprotective effects and mechanisms of action of artemisinin in retinal ganglion cells in a mouse model of traumatic optic neuropathy.

Zhou S, Li W, Lv R, Zhang M, Liu W Heliyon. 2024; 10(11):e31378.

PMID: 38828288 PMC: 11140598. DOI: 10.1016/j.heliyon.2024.e31378.


Uncovering the Genetics and Physiology behind Optic Neuritis.

Negro I, Pauletto G, Verriello L, Spadea L, Salati C, Ius T Genes (Basel). 2023; 14(12).

PMID: 38137014 PMC: 10742654. DOI: 10.3390/genes14122192.


Recent Advances of Adipose-Tissue-Derived Mesenchymal Stem Cell-Based Therapy for Retinal Diseases.

Finocchio L, Zeppieri M, Gabai A, Spadea L, Salati C J Clin Med. 2023; 12(22).

PMID: 38002628 PMC: 10672618. DOI: 10.3390/jcm12227015.


References
1.
Sluch V, Davis C, Ranganathan V, Kerr J, Krick K, Martin R . Differentiation of human ESCs to retinal ganglion cells using a CRISPR engineered reporter cell line. Sci Rep. 2015; 5:16595. PMC: 4643248. DOI: 10.1038/srep16595. View

2.
Cen L, Luo J, Geng Y, Zhang M, Pang C, Cui Q . Long-term survival and axonal regeneration of retinal ganglion cells after optic nerve transection and a peripheral nerve graft. Neuroreport. 2012; 23(11):692-7. DOI: 10.1097/WNR.0b013e328355f1d6. View

3.
Schwab M . Repairing the injured spinal cord. Science. 2002; 295(5557):1029-31. DOI: 10.1126/science.1067840. View

4.
Sun F, He Z . Neuronal intrinsic barriers for axon regeneration in the adult CNS. Curr Opin Neurobiol. 2010; 20(4):510-8. PMC: 2911501. DOI: 10.1016/j.conb.2010.03.013. View

5.
Li Y, Schlamp C, Nickells R . Experimental induction of retinal ganglion cell death in adult mice. Invest Ophthalmol Vis Sci. 1999; 40(5):1004-8. View